Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
10
ECG Quote, Financials, Valuation and Earnings
Last price:
$67.07
Seasonality move
:
--
Day range:
$62.56 - $67.39
52-week range:
$40.05 - $71.42
Dividend yield:
0%
P/E ratio:
25.37x
P/S ratio:
1.21x
P/B ratio:
7.54x
Volume:
1.2M
Avg. volume:
624.6K
1-year change:
--
Market cap:
$3.4B
Revenue:
$2.9B
EPS (TTM):
$2.64
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $2.1B | $2.7B | $2.9B | |
| Revenue Growth (YoY) | -- | -- | -- | 31.57% | 5.75% | |
| Cost of Revenues | -- | -- | $1.8B | $2.4B | $2.5B | |
| Gross Profit | -- | -- | $247.9M | $276M | $322.3M | |
| Gross Profit Margin | -- | -- | 12.09% | 10.23% | 11.29% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $102.2M | $111.4M | $142.1M | |
| Other Inc / (Exp) | -- | -- | $1.7M | $1.4M | $4.2M | |
| Operating Expenses | -- | -- | $102.2M | $111.4M | $142.1M | |
| Operating Income | -- | -- | $145.8M | $164.6M | $180.2M | |
| Net Interest Expenses | -- | -- | $3.5M | $6.4M | $27.9M | |
| EBT. Incl. Unusual Items | -- | -- | $144M | $159.7M | $156.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $35.4M | $40.8M | $42.6M | |
| Net Income to Company | -- | -- | $109.4M | $124.8M | $137.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | $109.4M | $124.8M | $118.8M | |
| Basic EPS (Cont. Ops) | -- | -- | $2.15 | $2.45 | $2.33 | |
| Diluted EPS (Cont. Ops) | -- | -- | $2.15 | $2.45 | $2.33 | |
| Weighted Average Basic Share | -- | -- | $51M | $51M | $51M | |
| Weighted Average Diluted Share | -- | -- | $51M | $51M | $51M | |
| EBITDA | -- | -- | $167.8M | $187.5M | $207.5M | |
| EBIT | -- | -- | $147.5M | $166M | $184.4M | |
| Revenue (Reported) | -- | -- | $2.1B | $2.7B | $2.9B | |
| Operating Income (Reported) | -- | -- | $145.8M | $164.6M | $180.2M | |
| Operating Income (Adjusted) | -- | -- | $147.5M | $166M | $184.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $717.4M | $761M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | 1.88% | |
| Cost of Revenues | -- | -- | -- | $632.5M | $671.1M | |
| Gross Profit | -- | -- | -- | $84.9M | $89.9M | |
| Gross Profit Margin | -- | -- | -- | 11.84% | 11.81% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $34.8M | $36.2M | |
| Other Inc / (Exp) | -- | -- | -- | $1.2M | $1.1M | |
| Operating Expenses | -- | -- | -- | $34.8M | $36.2M | |
| Operating Income | -- | -- | -- | $50.1M | $53.7M | |
| Net Interest Expenses | -- | -- | -- | $4.6M | $2.9M | |
| EBT. Incl. Unusual Items | -- | -- | -- | $46.7M | $51.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $11.4M | $14M | |
| Net Income to Company | -- | -- | -- | $100.7M | $109M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | $36M | $41.8M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | $0.71 | $0.82 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | $0.71 | $0.82 | |
| Weighted Average Basic Share | -- | -- | -- | $51M | $51M | |
| Weighted Average Diluted Share | -- | -- | -- | $51M | $51M | |
| EBITDA | -- | -- | -- | $57.2M | $61.1M | |
| EBIT | -- | -- | -- | $51.3M | $54.8M | |
| Revenue (Reported) | -- | -- | -- | $717.4M | $761M | |
| Operating Income (Reported) | -- | -- | -- | $50.1M | $53.7M | |
| Operating Income (Adjusted) | -- | -- | -- | $51.3M | $54.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $2.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | $2.5B | |
| Gross Profit | -- | -- | -- | -- | $343.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | $147.8M | |
| Other Inc / (Exp) | -- | -- | -- | $2M | $5.5M | |
| Operating Expenses | -- | -- | -- | -- | $147.8M | |
| Operating Income | -- | -- | -- | -- | $195.7M | |
| Net Interest Expenses | -- | -- | -- | $9.7M | $25.1M | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | $176M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $48.9M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | $134.8M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | $2.64 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | $2.64 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | $219.3M | |
| EBIT | -- | -- | -- | -- | $201.1M | |
| Revenue (Reported) | -- | -- | -- | -- | $2.8B | |
| Operating Income (Reported) | -- | -- | -- | -- | $195.7M | |
| Operating Income (Adjusted) | -- | -- | -- | -- | $201.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $1.5B | $1.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $1.3B | $1.3B | |
| Gross Profit | -- | -- | -- | $174.2M | $178.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $69.8M | $73.5M | |
| Other Inc / (Exp) | -- | -- | -- | $2M | $2.8M | |
| Operating Expenses | -- | -- | -- | $69.8M | $73.5M | |
| Operating Income | -- | -- | -- | $104.4M | $105M | |
| Net Interest Expenses | -- | -- | -- | $9.7M | $6.1M | |
| EBT. Incl. Unusual Items | -- | -- | -- | $96.7M | $101.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $24.6M | $27.6M | |
| Net Income to Company | -- | -- | -- | $165.5M | $176.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | $74.7M | $80.7M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | $1.47 | $1.58 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | $1.47 | $1.58 | |
| Weighted Average Basic Share | -- | -- | -- | $101.9M | $101.9M | |
| Weighted Average Diluted Share | -- | -- | -- | $101.9M | $101.9M | |
| EBITDA | -- | -- | -- | $112.4M | $114.1M | |
| EBIT | -- | -- | -- | $106.4M | $107.8M | |
| Revenue (Reported) | -- | -- | -- | $1.5B | $1.5B | |
| Operating Income (Reported) | -- | -- | -- | $104.4M | $105M | |
| Operating Income (Adjusted) | -- | -- | -- | $106.4M | $107.8M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $2.1M | $1.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | $573.5M | $536.8M | |
| Inventory | -- | -- | -- | $36.8M | $42.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | $13.3M | $17.7M | |
| Total Current Assets | -- | -- | -- | $788.1M | $766.1M | |
| Property Plant And Equipment | -- | -- | -- | $163.2M | $169.3M | |
| Long-Term Investments | -- | -- | -- | $3.4M | $8.4M | |
| Goodwill | -- | -- | -- | $143.2M | $143.2M | |
| Other Intangibles | -- | -- | -- | $4.1M | $2M | |
| Other Long-Term Assets | -- | -- | -- | $11.2M | $272K | |
| Total Assets | -- | -- | -- | $1.1B | $1.1B | |
| Accounts Payable | -- | -- | -- | $138.9M | $116.6M | |
| Accrued Expenses | -- | -- | -- | $50.8M | $48.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $27M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $20M | $21.1M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | $473.7M | $452.2M | |
| Long-Term Debt | -- | -- | -- | $224.1M | $168.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | $753.3M | $661.7M | |
| Common Stock | -- | -- | -- | $1K | $1K | |
| Other Common Equity Adj | -- | -- | -- | -$35K | -- | |
| Common Equity | -- | -- | -- | $382.2M | $448.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | $382.2M | $448.9M | |
| Total Liabilities and Equity | -- | -- | -- | $1.1B | $1.1B | |
| Cash and Short Terms | -- | -- | -- | $2.1M | $1.6M | |
| Total Debt | -- | -- | -- | $251.1M | $168.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | -- | $553K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | $633.2M | |
| Inventory | -- | -- | -- | -- | $46.9M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | $20.6M | |
| Total Current Assets | -- | -- | -- | -- | $886.5M | |
| Property Plant And Equipment | -- | -- | -- | -- | $198.2M | |
| Long-Term Investments | -- | -- | -- | -- | $17.6M | |
| Goodwill | -- | -- | -- | -- | $143.2M | |
| Other Intangibles | -- | -- | -- | -- | $466K | |
| Other Long-Term Assets | -- | -- | -- | -- | $360K | |
| Total Assets | -- | -- | -- | -- | $1.3B | |
| Accounts Payable | -- | -- | -- | -- | $160.9M | |
| Accrued Expenses | -- | -- | -- | -- | $54.1M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $26.1M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | $559.6M | |
| Long-Term Debt | -- | -- | -- | -- | $214.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | $826M | |
| Common Stock | -- | -- | -- | -- | $1K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | $453.3M | |
| Total Liabilities and Equity | -- | -- | -- | -- | $1.3B | |
| Cash and Short Terms | -- | -- | -- | -- | $553K | |
| Total Debt | -- | -- | -- | -- | $214.5M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $109.4M | $124.8M | $137.2M | |
| Depreciation & Amoritzation | -- | -- | $20.3M | $21.5M | $23.1M | |
| Stock-Based Compensation | -- | -- | $1.7M | $1.1M | $804K | |
| Change in Accounts Receivable | -- | -- | -$12.8M | -$239.9M | $30.8M | |
| Change in Inventories | -- | -- | -$2.1M | -$15.8M | -$5.9M | |
| Cash From Operations | -- | -- | $85.4M | -$25.5M | $171.3M | |
| Capital Expenditures | -- | -- | $27.3M | $35.8M | $35.6M | |
| Cash Acquisitions | -- | -- | -$2.5M | -- | -- | |
| Cash From Investing | -- | -- | $924K | -$24.6M | -$20M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $27M | -- | |
| Long-Term Debt Repaid | -- | -- | -$7K | -- | -$72M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$87.8M | $24.5M | -$79.9M | |
| Cash From Financing | -- | -- | -$87.8M | $51.5M | -$151.9M | |
| Beginning Cash (CF) | -- | -- | $2.1M | $668K | $2.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$1.4M | $1.4M | -$545K | |
| Ending Cash (CF) | -- | -- | $668K | $2.1M | $1.6M | |
| Levered Free Cash Flow | -- | -- | $58.2M | -$61.3M | $135.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $100.7M | $109M | |
| Depreciation & Amoritzation | -- | -- | -- | $17.2M | $18.5M | |
| Stock-Based Compensation | -- | -- | -- | $517K | $1M | |
| Change in Accounts Receivable | -- | -- | -- | -$49.2M | -$114.3M | |
| Change in Inventories | -- | -- | -- | -$9M | -$4.2M | |
| Cash From Operations | -- | -- | -- | $61.4M | $82.7M | |
| Capital Expenditures | -- | -- | -- | $28.1M | $34.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$16.4M | -$25.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$72M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | $25.5M | -$58.2M | |
| Cash From Financing | -- | -- | -- | -$46.5M | -$58.2M | |
| Beginning Cash (CF) | -- | -- | -- | $2.1M | $1.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$1.6M | -$1M | |
| Ending Cash (CF) | -- | -- | -- | $553K | $553K | |
| Levered Free Cash Flow | -- | -- | -- | $33.2M | $48.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | $739K | $2.2M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | $48.4M | $79.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | $29.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $165.5M | $176.1M | |
| Depreciation & Amoritzation | -- | -- | -- | $28.5M | $30.7M | |
| Stock-Based Compensation | -- | -- | -- | $739K | $1.7M | |
| Change in Accounts Receivable | -- | -- | -- | -$119.5M | -$204.3M | |
| Change in Inventories | -- | -- | -- | -$12.3M | -$10.1M | |
| Cash From Operations | -- | -- | -- | $42.9M | $86.4M | |
| Capital Expenditures | -- | -- | -- | $48.4M | $51M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$28.2M | -$37M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$144M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | $126.3M | -$51.7M | |
| Cash From Financing | -- | -- | -- | -$17.7M | -$51.7M | |
| Beginning Cash (CF) | -- | -- | -- | $4.2M | $3.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$3.1M | -$2.3M | |
| Ending Cash (CF) | -- | -- | -- | $1.2M | $875K | |
| Levered Free Cash Flow | -- | -- | -- | -$5.6M | $35.4M | |
Get ECG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ECG
Sector
P/E ratio
25.37x
17.94x
PEG ratio
--
0.34x
P/B ratio
7.54x
1.76x
Price / LTM sales
1.21x
0.97x
Growth Metrics
ECG
Sector
Revenue growth
1.88%
1.77%
Earnings growth
8.15%
1.67%
Revenue (5-year growth)
--
4.31%
Earnings forecast
--
$0.46
Profitability
ECG
Sector
Profitability FY 2023
$322.3M
$434.2M
Return on invested capital
20.01%
5.93%
Return on assets
11.02%
3.69%
Return on equity
31.05%
8.87%
Earnings Date
Last Earnings Date
Dec
23
Next Earnings Date
Dec
23
Estimated Next Earnings Date
Mar
24
Balance Sheet
ECG
Sector
Total cash
$553K
$170.4M
Short term investments
--
$46.5M
Total assets
$1.1B
$2.1B
Long term debt
$214.5M
$147.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
